Scientific Background: Bachelor’s Degree in Biology with Majors in Genetics from Universidad Complutense de Madrid and Ph.D. in Neuroscience from Universidad Autónoma de Madrid, Spain. After a first postdoctoral stage at Centro de Biologia Molecular Severo Ochoa in Madrid on stem cell-based therapies for neurodegenerative disorders and a second postdoctoral stage on gene therapy for neurodegenerative disorders in Lund University, Sweden, she now holds a researcher position developing her role as group leader at Lund Stem Cell Center and is soon to start her own company for treating mental health disabilities. Committed to improve the life of people suffering from mental health disabilities through educational initiatives and research on the development of novel treatment strategies, her resilience as a sister of a person affected by a rare syndrome and as a researcher pioneering gene and cell-based therapies for the nervous system’s affections enables her to lead others to improve the quality of life of people affected by a mental disability.
Goals within ACES: Tania believes in ACES as the link between Spain and Sweden at a professional level. For her, ACES is also a platform to improve the recognition of Spanish science in Scandinavia and, in addition, gives her the possibility to work towards the recognition of women in research through RAICEX. She also believes ACES can work with Spanish political instruments to export the Scandinavian model in research to Spain. Moreover, Tania is committed to spread science through ACES and RAICEX in a popular way to favor the knowledge of rare affections and mental health disabilities in society.